Dataset from A Phase III, Open-Label, Randomized Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00007372
下载链接
链接失效反馈官方服务：
资源简介：
This study will evaluate the efficacy and safety of atezolizumab in combination with
bevacizumab compared with sorafenib in participants with locally advanced or metastatic
Hepatocellular Carcinoma (HCC) who have received no prior systemic treatment.
创建时间：
2026-04-09
